{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:51:47Z","timestamp":1792691507344,"version":"4.5.0"},"reference-count":258,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12035-025-05026-w","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T01:12:21Z","timestamp":1746839541000},"page":"14683-14705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases"],"prefix":"10.1007","volume":"62","author":[{"given":"Vibhav","family":"Varshney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baneen C.","family":"Gabble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Bishoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarraa Ahmad","family":"Qahtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajashree","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Nathiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"5026_CR1","doi-asserted-by":"publisher","unstructured":"Pathak N, Vimal SK, Tandon I, Agrawal L, Hongyi C, Bhattacharyya S (2021) Neurodegenerative disorders of alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment. Metab Brain Dis 1\u201338. https:\/\/doi.org\/10.1007\/s11011-021-00800-w","DOI":"10.1007\/s11011-021-00800-w"},{"issue":"2","key":"5026_CR2","first-page":"4328","volume":"6","author":"H Sharma","year":"2024","unstructured":"Sharma H, Chandra P, Pathak R, Bhandari M (2024) Advancements in the therapeutic approaches to treat neurological disorders. CAHIERS MAGELLANES-NS 6(2):4328\u20134389","journal-title":"CAHIERS MAGELLANES-NS"},{"issue":"3","key":"5026_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/molecules29030722","volume":"29","author":"N Bisi","year":"2024","unstructured":"Bisi N, Pinzi L, Rastelli G, Tonali N (2024) Early diagnosis of neurodegenerative diseases: what has been undertaken to promote the transition from PET to fluorescence tracers. Molecules 29(3):722. https:\/\/doi.org\/10.3390\/molecules29030722","journal-title":"Molecules"},{"key":"5026_CR4","doi-asserted-by":"publisher","first-page":"112280","DOI":"10.1016\/j.microc.2024.112280","volume":"208","author":"R Thakur","year":"2025","unstructured":"Thakur R, Saini AK, Taliyan R, Chaturvedi N (2025) Neurodegenerative diseases early detection and monitoring system for point-of-care applications. Microchem J 208:112280","journal-title":"Microchem J"},{"issue":"9","key":"5026_CR5","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.3390\/s23094184","volume":"23","author":"AG Vrahatis","year":"2023","unstructured":"Vrahatis AG, Skolariki K, Krokidis MG, Lazaros K, Exarchos TP, Vlamos P (2023) Revolutionizing the early detection of Alzheimer\u2019s disease through non-invasive biomarkers: the role of artificial intelligence and deep learning. Sensors 23(9):4184","journal-title":"Sensors"},{"issue":"11","key":"5026_CR6","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3390\/pharmaceutics15112599","volume":"15","author":"SK Niazi","year":"2023","unstructured":"Niazi SK (2023) Non-invasive drug delivery across the blood\u2013brain barrier: a prospective analysis. Pharmaceutics 15(11):2599","journal-title":"Pharmaceutics"},{"key":"5026_CR7","first-page":"399","volume-title":"Koduru TS","author":"P Halagali","year":"2025","unstructured":"Halagali P, Nayak D, Tippavajhala VK, Rathnanand M, Biswas D, Sharma H (2025) Chapter 16 - Navigating the nanoscopic frontier: Ethical dimensions in developing nanocarriers for neurodegenerative diseases. In: Osmani RAM, Singh E, Dutta S (eds) Koduru TS. Academic Press, The Neurodegeneration Revolution, pp 399\u2013420"},{"issue":"3","key":"5026_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13206-023-00112-4","volume":"17","author":"I Haizan","year":"2023","unstructured":"Haizan I, Park DH, Choi MY, Lee H, Choi J-H (2023) Nanomaterials-based exosomes for the diagnostics and drug deliveries of central nervous system diseases. BioChip J 17(3):293\u2013307","journal-title":"BioChip J"},{"issue":"3\u20134","key":"5026_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/prca.201400114","volume":"9","author":"S Boukouris","year":"2015","unstructured":"Boukouris S, Mathivanan S (2015) Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics-Clin Appl 9(3\u20134):358\u201367","journal-title":"Proteomics-Clin Appl"},{"key":"5026_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/266608222101240903153003","volume":"21","author":"S Subhajit","year":"2025","unstructured":"Subhajit S, Utpal B, Bimlesh K, Sumel A, Prashant K, Himanshu S et al (2025) Correlation between cognitive impairment and peripheral biomarkers - significance of phosphorylated tau and amyloid-\u03b2 in alzheimer\u2019s disease: a new insight. Cur Psychiat Res Rev 21:1\u201325","journal-title":"Cur Psychiat Res Rev"},{"key":"5026_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-981-99-3848-3_10","volume-title":"Applications of stem cells and derived exosomes in neurodegenerative disorders","author":"S Ali","year":"2023","unstructured":"Ali S, Mukherjee S, Goel D, Ghosh A, Faruq M (2023) Role of stem cells and derived exosomes as a novel therapeutic agent against alzheimer\u2019s and parkinson\u2019s disease. In: Jahan S, Siddiqui AJ (eds) Applications of stem cells and derived exosomes in neurodegenerative disorders. Springer, Singapore, pp 231\u2013258. https:\/\/doi.org\/10.1007\/978-981-99-3848-3_10"},{"key":"5026_CR12","first-page":"1","volume-title":"Exosomes based drug delivery strategies for brain disorders","author":"H Sharma","year":"2024","unstructured":"Sharma H, Rachamalla HK, Mishra N, Chandra P, Pathak R, Ashique S (2024) Introduction to exosome and its role in brain disorders. In: Mishra N, Ashique S, Garg A, Chithravel V, Anand K (eds) Exosomes based drug delivery strategies for brain disorders. Springer Nature Singapore, Singapore, pp 1\u201335"},{"key":"5026_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.reth.2024.01.009","volume":"25","author":"R Long","year":"2024","unstructured":"Long R, Wang S (2024) Exosomes from preconditioned mesenchymal stem cells: Tissue repair and regeneration. Regene Therapy 25:355\u2013366","journal-title":"Regene Therapy"},{"issue":"12","key":"5026_CR14","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1007\/s12035-022-03028-6","volume":"59","author":"L Zhang","year":"2022","unstructured":"Zhang L, Mao L, Wang H (2022) The neuroprotection effects of exosome in central nervous system injuries: a new target for therapeutic intervention. Mol Neurobiol 59(12):7152\u20137169","journal-title":"Mol Neurobiol"},{"key":"5026_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fncel.2017.00055","volume":"11","author":"Y Yang","year":"2017","unstructured":"Yang Y, Ye Y, Su X, He J, Bai W, He X (2017) MSCs-derived exosomes and neuroinflammation, neurogenesis and therapy of traumatic brain injury. Front Cell Neurosci 11:55","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"5026_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/brainsci14111049","volume":"14","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yang Y, Lv X, Zhou X, Zhao W, Meng L et al (2024) Exosome cargo in neurodegenerative diseases: leveraging their intercellular communication capabilities for biomarker discovery and therapeutic delivery. Brain Sci 14(11):1049","journal-title":"Brain Sci"},{"key":"5026_CR17","doi-asserted-by":"publisher","first-page":"113938","DOI":"10.1016\/j.colsurfb.2024.113938","volume":"239","author":"X Tang","year":"2024","unstructured":"Tang X, He Y, Liu J, Xu J, Peng Q (2024) Exosomes: the endogenous nanomaterials packed with potential for diagnosis and treatment of neurologic disorders. Colloids Surf B: Biointerfaces 239:113938","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"10","key":"5026_CR18","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X (2023) Current strategies for exosome cargo loading and targeting delivery. Cells 12(10):1416. https:\/\/doi.org\/10.3390\/cells12101416","journal-title":"Cells"},{"key":"5026_CR19","doi-asserted-by":"publisher","first-page":"101155","DOI":"10.1016\/j.mam.2022.101155","volume":"91","author":"DJ Beetler","year":"2023","unstructured":"Beetler DJ, Di Florio DN, Bruno KA, Ikezu T, March KL, Cooper LT Jr et al (2023) Extracellular vesicles as personalized medicine. Mol Aspects Med 91:101155","journal-title":"Mol Aspects Med"},{"issue":"44","key":"5026_CR20","doi-asserted-by":"publisher","first-page":"16029","DOI":"10.1021\/acs.analchem.3c02224","volume":"95","author":"A Oz","year":"2023","unstructured":"Oz A, Ye S (2023) Exploring the versatility of exosomes: a review on isolation, characterization, detection methods, and diverse applications. Anal Chem 95(44):16029\u201316048","journal-title":"Anal Chem"},{"issue":"6","key":"5026_CR21","first-page":"804","volume":"11","author":"MA Di Bella","year":"2022","unstructured":"Di Bella MA (2022) Overview and update on extracellular vesicles: considerations on exosomes and their application in modern medicine. Biology (Basel) 11(6):804","journal-title":"Biology (Basel)"},{"issue":"3","key":"5026_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11518","volume":"24","author":"I Maligianni","year":"2022","unstructured":"Maligianni I, Yapijakis C, Nousia K, Bacopoulou F, Chrousos GP (2022) Exosomes and exosomal non-coding RNAs throughout human gestation. Exp Ther Med 24(3):1\u201313","journal-title":"Exp Ther Med"},{"issue":"6478","key":"5026_CR23","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R (2020) LeBleu VS The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977","journal-title":"Science"},{"issue":"5","key":"5026_CR24","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","volume":"10","author":"M Xu","year":"2023","unstructured":"Xu M, Ji J, Jin D, Wu Y, Wu T, Lin R et al (2023) The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases. Genes & Diseases 10(5):1894\u20131907","journal-title":"Genes & Diseases"},{"issue":"3","key":"5026_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/10409238.2014.881777","volume":"49","author":"AL Schuh","year":"2014","unstructured":"Schuh AL, Audhya A (2014) The ESCRT machinery: from the plasma membrane to endosomes and back again. Crit Rev Biochem Mol Biol 49(3):242\u2013261","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"23","key":"5026_CR26","doi-asserted-by":"publisher","first-page":"15317","DOI":"10.3390\/ijms232315317","volume":"23","author":"R Horbay","year":"2022","unstructured":"Horbay R, Hamraghani A, Ermini L, Holcik S, Beug ST, Yeganeh B (2022) Role of ceramides and lysosomes in extracellular vesicle biogenesis, cargo sorting and release. Int J Mol Sci 23(23):15317","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5026_CR27","doi-asserted-by":"publisher","first-page":"108255","DOI":"10.1016\/j.jbc.2025.108255","volume":"301","author":"LC Duke","year":"2025","unstructured":"Duke LC, Cone AS, Sun L, Dittmer DP, Meckes DG, Tomko RJ Jr (2025) Tetraspanin CD9 alters cellular trafficking and endocytosis of tetraspanin CD63, affecting CD63 packaging into small extracellular vesicles. J Biol Chem 301(3):108255. https:\/\/doi.org\/10.1016\/j.jbc.2025.108255","journal-title":"J Biol Chem"},{"key":"5026_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jconrel.2016.02.037","volume":"228","author":"SW Ferguson","year":"2016","unstructured":"Ferguson SW, Nguyen J (2016) Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity. J Control Release 228:179\u2013190","journal-title":"J Control Release"},{"key":"5026_CR29","doi-asserted-by":"publisher","first-page":"115087","DOI":"10.1016\/j.biopha.2023.115087","volume":"165","author":"J Li","year":"2023","unstructured":"Li J, Zhang Y, Dong P-Y, Yang G-M, Gurunathan S (2023) A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. Biomed Pharmacother 165:115087","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5026_CR30","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.3390\/ijms14035338","volume":"14","author":"C Corrado","year":"2013","unstructured":"Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R (2013) Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci 14(3):5338\u20135366","journal-title":"Int J Mol Sci"},{"key":"5026_CR31","doi-asserted-by":"publisher","first-page":"1198044","DOI":"10.3389\/fmolb.2023.1198044","volume":"10","author":"S Ghadami","year":"2023","unstructured":"Ghadami S, Dellinger K (2023) The lipid composition of extracellular vesicles: applications in diagnostics and therapeutic delivery. Front Mol Biosci 10:1198044","journal-title":"Front Mol Biosci"},{"key":"5026_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.virol.2015.04.022","volume":"483","author":"V Shivanna","year":"2015","unstructured":"Shivanna V, Kim Y, Chang K-O (2015) Ceramide formation mediated by acid sphingomyelinase facilitates endosomal escape of caliciviruses. Virology 483:218\u2013228","journal-title":"Virology"},{"key":"5026_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.virol.2023.02.012","volume":"581","author":"SB York","year":"2023","unstructured":"York SB, Hurwitz SN, Liu X, Meckes DG Jr (2023) Ceramide-dependent trafficking of Epstein-Barr virus LMP1 to small extracellular vesicles. Virology 581:128\u2013138","journal-title":"Virology"},{"issue":"9","key":"5026_CR34","doi-asserted-by":"publisher","first-page":"jcs260887","DOI":"10.1242\/jcs.260887","volume":"136","author":"K Sapo\u0144","year":"2023","unstructured":"Sapo\u0144 K, Ma\u0144ka R, Janas T, Janas T (2023) The role of lipid rafts in vesicle formation. J Cell Sci 136(9):jcs260887","journal-title":"J Cell Sci"},{"issue":"4","key":"5026_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/aps.2017.162","volume":"39","author":"S Samanta","year":"2018","unstructured":"Samanta S, Rajasingh S, Drosos N, Zhou Z, Dawn B, Rajasingh J (2018) Exosomes: new molecular targets of diseases. Acta Pharmacol Sin 39(4):501\u2013513","journal-title":"Acta Pharmacol Sin"},{"issue":"16","key":"5026_CR36","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.3390\/ijms21165866","volume":"21","author":"A-A Zimta","year":"2020","unstructured":"Zimta A-A, Sigurjonsson OE, Gulei D, Tomuleasa C (2020) The malignant role of exosomes as nanocarriers of rare RNA species. Int J Mol Sci 21(16):5866","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5026_CR37","doi-asserted-by":"publisher","first-page":"e21916","DOI":"10.1096\/fj.202100294RR","volume":"35","author":"B Li","year":"2021","unstructured":"Li B, Cao Y, Sun M, Feng H (2021) Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy. FASEB J 35(10):e21916","journal-title":"FASEB J"},{"key":"5026_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6150-8-12","volume":"8","author":"AO Batagov","year":"2013","unstructured":"Batagov AO, Kurochkin IV (2013) Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3\u2032-untranslated regions. Biol Direct 8:1\u20138","journal-title":"Biol Direct"},{"issue":"1","key":"5026_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/ijms22010440","volume":"22","author":"S Rastogi","year":"2021","unstructured":"Rastogi S, Sharma V, Bharti PS, Rani K, Modi GP, Nikolajeff F et al (2021) The evolving landscape of exosomes in neurodegenerative diseases: exosomes characteristics and a promising role in early diagnosis. Int J Mol Sci 22(1):440","journal-title":"Int J Mol Sci"},{"issue":"17","key":"5026_CR40","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.3390\/ijms20174113","volume":"20","author":"P Riva","year":"2019","unstructured":"Riva P, Battaglia C, Venturin M (2019) Emerging role of genetic alterations affecting exosome biology in neurodegenerative diseases. Int J Mol Sci 20(17):4113","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5026_CR41","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","volume":"20","author":"J Ratajczak","year":"2006","unstructured":"Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak M (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20(9):1487\u20131495","journal-title":"Leukemia"},{"key":"5026_CR42","doi-asserted-by":"publisher","first-page":"752595","DOI":"10.3389\/fneur.2021.752595","volume":"12","author":"C Li","year":"2021","unstructured":"Li C, Ke C, Su Y, Wan C (2021) Exercise intervention promotes the growth of synapses and regulates neuroplasticity in rats with ischemic stroke through exosomes. Front Neurol 12:752595","journal-title":"Front Neurol"},{"key":"5026_CR43","doi-asserted-by":"publisher","first-page":"1185883","DOI":"10.3389\/fnmol.2023.1185883","volume":"16","author":"M Kodali","year":"2023","unstructured":"Kodali M, Madhu LN, Reger RL, Milutinovic B, Upadhya R, Attaluri S et al (2023) A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling. Front Mol Neurosci 16:1185883","journal-title":"Front Mol Neurosci"},{"key":"5026_CR44","doi-asserted-by":"publisher","first-page":"601600","DOI":"10.3389\/fcell.2021.601600","volume":"9","author":"P Yuan","year":"2021","unstructured":"Yuan P, Ding L, Chen H, Wang Y, Li C, Zhao S et al (2021) Neural stem cell-derived exosomes regulate neural stem cell differentiation through miR-9-Hes1 axis. Frontiers in Cell and Developmental Biology 9:601600","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"5026_CR45","doi-asserted-by":"publisher","first-page":"882306","DOI":"10.3389\/fncel.2022.882306","volume":"16","author":"Z-L Yang","year":"2022","unstructured":"Yang Z-L, Rao J, Lin F-B, Liang Z-Y, Xu X-J, Lin Y-K et al (2022) The role of exosomes and exosomal noncoding RNAs from different cell sources in spinal cord injury. Front Cell Neurosci 16:882306","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"5026_CR46","doi-asserted-by":"publisher","first-page":"796","DOI":"10.4103\/1673-5374.268893","volume":"15","author":"M Pascual","year":"2020","unstructured":"Pascual M, Ib\u00e1\u00f1ez F, Guerri C (2020) Exosomes as mediators of neuron-glia communication in neuroinflammation. Neural Regen Res 15(5):796\u2013801","journal-title":"Neural Regen Res"},{"key":"5026_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-981-99-8373-5_11","volume-title":"Exosomes Based Drug Delivery Strategies for Brain Disorders","author":"P Kumar","year":"2024","unstructured":"Kumar P, Sharma H, Singh A, Pandey SN, Chandra P (2024) Correlation Between Exosomes and Neuro-inflammation in Various Brain Disorders. In: Mishra N, Ashique S, Garg A, Chithravel V, Anand K (eds) Exosomes Based Drug Delivery Strategies for Brain Disorders. Springer Nature Singapore, Singapore, pp 273\u2013302"},{"issue":"2","key":"5026_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/ijms17020173","volume":"17","author":"LJ Vella","year":"2016","unstructured":"Vella LJ, Hill AF, Cheng L (2016) Focus on extracellular vesicles: exosomes and their role in protein trafficking and biomarker potential in Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 17(2):173","journal-title":"Int J Mol Sci"},{"key":"5026_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-981-99-8373-5_6","volume-title":"Exosomes Based Drug Delivery Strategies for Brain Disorders","author":"H Sharma","year":"2024","unstructured":"Sharma H, Tyagi SJ, Chandra P, Verma A, Kumar P, Ashique S et al (2024) Role of Exosomes in Parkinson\u2019s and Alzheimer\u2019s Diseases. In: Mishra N, Ashique S, Garg A, Chithravel V, Anand K (eds) Exosomes Based Drug Delivery Strategies for Brain Disorders. Springer Nature Singapore, Singapore, pp 147\u2013182"},{"key":"5026_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-018-1868-1","volume":"136","author":"M Sardar Sinha","year":"2018","unstructured":"Sardar Sinha M, Ansell-Schultz A, Civitelli L, Hildesj\u00f6 C, Larsson M, Lannfelt L et al (2018) Alzheimer\u2019s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol 136:41\u201356","journal-title":"Acta Neuropathol"},{"issue":"22","key":"5026_CR51","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1111\/febs.16055","volume":"289","author":"JC Polanco","year":"2022","unstructured":"Polanco JC, G\u00f6tz J (2022) Exosomal and vesicle-free tau seeds\u2014propagation and convergence in endolysosomal permeabilization. FEBS J 289(22):6891\u20136907","journal-title":"FEBS J"},{"issue":"Pt.2","key":"5026_CR52","doi-asserted-by":"publisher","first-page":"130728","DOI":"10.1016\/j.ijbiomac.2024.130728","volume":"264","author":"G Singh","year":"2024","unstructured":"Singh G, Mehra A, Arora S, Gugulothu D, Vora L, Prasad R et al (2024) Exosome-mediated delivery and regulation in neurological disease progression. International Journal of Biological Macromolecules 264(Pt.2):130728. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130728","journal-title":"International Journal of Biological Macromolecules"},{"key":"5026_CR53","doi-asserted-by":"publisher","first-page":"100835","DOI":"10.1016\/j.bbih.2024.100835","volume":"40","author":"K Sankarappan","year":"2024","unstructured":"Sankarappan K, Shetty AK (2024) Promise of mesenchymal stem cell-derived extracellular vesicles for alleviating subarachnoid hemorrhage-induced brain dysfunction by neuroprotective and antiinflammatory effects. Brain, Behavior, & Immunity-Health 40:100835","journal-title":"Brain, Behavior, & Immunity-Health"},{"issue":"1","key":"5026_CR54","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12951-023-02081-0","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu Q, Li D, Pan X, Liang Y (2023) Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. J Nanobiotechnology 21(1):334","journal-title":"J Nanobiotechnology"},{"key":"5026_CR55","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","volume":"67","author":"Z Li","year":"2019","unstructured":"Li Z, Liu F, He X, Yang X, Shan F, Feng J (2019) Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int Immunopharmacol 67:268\u2013280","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5026_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10571-024-01460-x","volume":"44","author":"Y Ge","year":"2024","unstructured":"Ge Y, Wu J, Zhang L, Huang N, Luo Y (2024) A new strategy for the regulation of neuroinflammation: exosomes derived from mesenchymal stem cells. Cell Mol Neurobiol 44(1):24","journal-title":"Cell Mol Neurobiol"},{"key":"5026_CR57","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.2147\/IJN.S464249","volume":"19","author":"M Bahadorani","year":"2024","unstructured":"Bahadorani M, Nasiri M, Dellinger K, Aravamudhan S, Zadegan R (2024) Engineering exosomes for therapeutic applications: decoding biogenesis, content modification, and cargo loading strategies. Intern J Nanomedicine 19:7137\u201364. https:\/\/doi.org\/10.2147\/IJN.S464249","journal-title":"Intern J Nanomedicine"},{"key":"5026_CR58","doi-asserted-by":"publisher","first-page":"1344705","DOI":"10.3389\/fcell.2024.1344705","volume":"12","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wang Q, Qin F, Chen J (2024) Exosomes: a promising avenue for cancer diagnosis beyond treatment. Frontiers in Cell and Developmental Biology 12:1344705","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"5026_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12929-024-01055-0","volume":"31","author":"Y-F Chen","year":"2024","unstructured":"Chen Y-F, Luh F, Ho Y-S, Yen Y (2024) Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. J Biomed Sci 31(1):67","journal-title":"J Biomed Sci"},{"issue":"8","key":"5026_CR60","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","volume":"15","author":"L Jia","year":"2019","unstructured":"Jia L, Qiu Q, Zhang H, Chu L, Du Y, Zhang J et al (2019) Concordance between the assessment of A\u03b242, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement 15(8):1071\u20131080","journal-title":"Alzheimers Dement"},{"key":"5026_CR61","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1007\/s12035-018-1032-x","volume":"55","author":"PM McKeever","year":"2018","unstructured":"McKeever PM, Schneider R, Taghdiri F, Weichert A, Multani N, Brown RA et al (2018) MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer\u2019s disease. Mol Neurobiol 55:8826\u20138841","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5026_CR62","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41398-019-0579-2","volume":"9","author":"G Jain","year":"2019","unstructured":"Jain G, Stuendl A, Rao P, Berulava T, Pena Centeno T, Kaurani L et al (2019) A combined miRNA\u2013piRNA signature to detect Alzheimer\u2019s disease. Transl Psychiatry 9(1):250","journal-title":"Transl Psychiatry"},{"issue":"9","key":"5026_CR63","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cells9091959","volume":"9","author":"S Muraoka","year":"2020","unstructured":"Muraoka S, Jedrychowski MP, Yanamandra K, Ikezu S, Gygi SP, Ikezu T (2020) Proteomic profiling of extracellular vesicles derived from cerebrospinal fluid of Alzheimer\u2019s disease patients: a pilot study. Cells 9(9):1959","journal-title":"Cells"},{"issue":"35","key":"5026_CR64","doi-asserted-by":"publisher","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y, Liu H, Zhang L, Lv W, Hu X (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6(35):37043","journal-title":"Oncotarget"},{"issue":"11","key":"5026_CR65","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1096\/fj.201600756R","volume":"30","author":"EJ Goetzl","year":"2016","unstructured":"Goetzl EJ, Mustapic M, Kapogiannis D, Eitan E, Lobach IV, Goetzl L et al (2016) Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer\u2019s disease. FASEB J 30(11):3853","journal-title":"FASEB J"},{"key":"5026_CR66","first-page":"61","volume":"11","author":"CN Winston","year":"2019","unstructured":"Winston CN, Goetzl EJ, Schwartz JB, Elahi FM, Rissman RA (2019) Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer\u2019s disease dementia. Alzheim & Dement: Diag, Assess & Dis Monit 11:61\u201366","journal-title":"Alzheim & Dement: Diag, Assess & Dis Monit"},{"key":"5026_CR67","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fnagi.2020.00166","volume":"12","author":"N Zhang","year":"2020","unstructured":"Zhang N, Gu D, Meng M, Gordon ML (2020) TDP-43 is elevated in plasma neuronal-derived exosomes of patients with Alzheimer\u2019s disease. Frontiers in Aging Neuroscience 12:166","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"5026_CR68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","volume":"85","author":"EJ Goetzl","year":"2015","unstructured":"Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL et al (2015) Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85(1):40\u201347","journal-title":"Neurology"},{"key":"5026_CR69","first-page":"63","volume":"3","author":"CN Winston","year":"2016","unstructured":"Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D et al (2016) Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheim & Dement: Diag, Assess & Dis Monit 3:63\u201372","journal-title":"Alzheim & Dement: Diag, Assess & Dis Monit"},{"issue":"8","key":"5026_CR70","doi-asserted-by":"publisher","first-page":"e036990","DOI":"10.1136\/bmjopen-2020-036990","volume":"10","author":"M He","year":"2020","unstructured":"He M, Sun L, Cao W, Yin C, Sun W, Liu P et al (2020) Association between plasma exosome neurogranin and brain structure in patients with Alzheimer\u2019s disease: A protocol study. BMJ Open 10(8):e036990","journal-title":"BMJ Open"},{"key":"5026_CR71","doi-asserted-by":"publisher","first-page":"108980","DOI":"10.1016\/j.jneumeth.2020.108980","volume":"347","author":"K Rani","year":"2021","unstructured":"Rani K, Rastogi S, Vishwakarma P, Bharti PS, Sharma V, Renu K et al (2021) A novel approach to correlate the salivary exosomes and their protein cargo in the progression of cognitive impairment into Alzheimer\u2019s disease. J Neurosci Methods 347:108980","journal-title":"J Neurosci Methods"},{"key":"5026_CR72","doi-asserted-by":"publisher","first-page":"565479","DOI":"10.3389\/fgene.2020.565479","volume":"11","author":"Z Song","year":"2020","unstructured":"Song Z, Xu Y, Zhang L, Zhou L, Zhang Y, Han Y et al (2020) Comprehensive proteomic profiling of urinary exosomes and identification of potential non-invasive early biomarkers of Alzheimer\u2019s disease in 5XFAD mouse model. Front Genet 11:565479","journal-title":"Front Genet"},{"issue":"5\u20136","key":"5026_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000505851","volume":"19","author":"R Sun","year":"2019","unstructured":"Sun R, Wang H, Shi Y, Gao D, Sun Z, Chen Z et al (2019) A pilot study of urinary exosomes in Alzheimer\u2019s disease. Neurodegener Dis 19(5\u20136):184\u2013191","journal-title":"Neurodegener Dis"},{"issue":"5","key":"5026_CR74","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M, Wang J, Zhao Y, Feng Y, Han S, Dong Q et al (2020) Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease. Brain 143(5):1476\u20131497","journal-title":"Brain"},{"key":"5026_CR75","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.omtn.2017.04.010","volume":"7","author":"J Yang","year":"2017","unstructured":"Yang J, Zhang X, Chen X, Wang L, Yang G (2017) Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Molecular Therapy-Nucleic Acids 7:278\u2013287","journal-title":"Molecular Therapy-Nucleic Acids"},{"issue":"3","key":"5026_CR76","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.3390\/ijms16034800","volume":"16","author":"P Joshi","year":"2015","unstructured":"Joshi P, Benussi L, Furlan R, Ghidoni R, Verderio C (2015) Extracellular vesicles in Alzheimer\u2019s disease: friends or foes? Focus on a\u03b2-vesicle interaction. Int J Mol Sci 16(3):4800\u20134813","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5026_CR77","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s13311-020-00842-5","volume":"17","author":"J Zou","year":"2020","unstructured":"Zou J, Guo Y, Wei L, Yu F, Yu B, Xu A (2020) Long noncoding RNA POU3F3 and \u03b1-synuclein in plasma L1CAM exosomes combined with \u03b2-glucocerebrosidase activity: potential predictors of Parkinson\u2019s disease. Neurotherapeutics 17(3):1104\u20131119","journal-title":"Neurotherapeutics"},{"key":"5026_CR78","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.11.021","volume":"61","author":"T Ohmichi","year":"2019","unstructured":"Ohmichi T, Mitsuhashi M, Tatebe H, Kasai T, El-Agnaf OMA, Tokuda T (2019) Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson\u2019s and related diseases. Parkinsonism Relat Disord 61:82\u201387","journal-title":"Parkinsonism Relat Disord"},{"key":"5026_CR79","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","volume":"10","author":"Z-H Zhao","year":"2019","unstructured":"Zhao Z-H, Chen Z-T, Zhou R-L, Zhang X, Ye Q-Y, Wang Y-Z (2019) Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease. Front Aging Neurosci 10:438","journal-title":"Front Aging Neurosci"},{"key":"5026_CR80","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","volume":"696","author":"Z Cao","year":"2019","unstructured":"Cao Z, Wu Y, Liu G, Jiang Y, Wang X, Wang Z et al (2019) \u03b1-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett 696:114\u2013120","journal-title":"Neurosci Lett"},{"key":"5026_CR81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2019.09.008","volume":"67","author":"K Rani","year":"2019","unstructured":"Rani K, Mukherjee R, Singh E, Kumar S, Sharma V, Vishwakarma P et al (2019) Neuronal exosomes in saliva of Parkinson\u2019s disease patients: A pilot study. Parkinsonism Relat Disord 67:21\u201323","journal-title":"Parkinsonism Relat Disord"},{"issue":"24","key":"5026_CR82","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1093\/hmg\/ddt346","volume":"22","author":"KB Fraser","year":"2013","unstructured":"Fraser KB, Moehle MS, Daher JP, Webber PJ, Williams JY, Stewart CA et al (2013) LRRK2 secretion in exosomes is regulated by 14-3-3. Hum Mol Genet 22(24):4988\u20135000","journal-title":"Hum Mol Genet"},{"key":"5026_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-017-0492-y","volume":"5","author":"S Wang","year":"2017","unstructured":"Wang S, Liu Z, Ye T, Mabrouk OS, Maltbie T, Aasly J et al (2017) Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers. Acta Neuropathol Commun 5:1\u201313","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"5026_CR84","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1212\/WNL.0000000000004844","volume":"90","author":"ER Reed","year":"2018","unstructured":"Reed ER, Latourelle JC, Bockholt JH, Bregu J, Smock J, Paulsen JS et al (2018) MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology 90(4):e264\u2013e272","journal-title":"Neurology"},{"key":"5026_CR85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.pmbts.2016.12.013","volume":"146","author":"S Kumar","year":"2017","unstructured":"Kumar S, Vijayan M, Bhatti JS, Reddy PH (2017) MicroRNAs as Peripheral Biomarkers in Aging and Age-Related Diseases. Prog Mol Biol Transl Sci 146:47\u201394","journal-title":"Prog Mol Biol Transl Sci"},{"key":"5026_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fnins.2017.00149","volume":"11","author":"JK Wang","year":"2017","unstructured":"Wang JK, Langfelder P, Horvath S, Palazzolo MJ (2017) Exosomes and homeostatic synaptic plasticity are linked to each other and to Huntington\u2019s, Parkinson\u2019s, and other neurodegenerative diseases by database-enabled analyses of comprehensively curated datasets. Front Neurosci 11:149","journal-title":"Front Neurosci"},{"issue":"1","key":"5026_CR87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5582\/irdr.2017.01091","volume":"7","author":"Q Xu","year":"2018","unstructured":"Xu Q, Zhao Y, Zhou X, Luan J, Cui Y, Han J (2018) Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients. Intractable & Rare Dis Res 7(1):13\u201318","journal-title":"Intractable & Rare Dis Res"},{"key":"5026_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-019-0473-z","volume":"12","author":"K Otake","year":"2019","unstructured":"Otake K, Kamiguchi H, Hirozane Y (2019) Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. BMC Med Genomics 12:1\u201311","journal-title":"BMC Med Genomics"},{"issue":"5\u20136","key":"5026_CR89","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","volume":"15","author":"E Feneberg","year":"2014","unstructured":"Feneberg E, Steinacker P, Lehnert S, Schneider A, Walther P, Thal DR et al (2014) Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15(5\u20136):351\u2013356","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"6","key":"5026_CR90","doi-asserted-by":"publisher","first-page":"200116","DOI":"10.1098\/rsob.200116","volume":"10","author":"SA Banack","year":"2020","unstructured":"Banack SA, Dunlop RA, Cox PA (2020) An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis\/motor neuron disease. Open Biol 10(6):200116","journal-title":"Open Biol"},{"key":"5026_CR91","doi-asserted-by":"publisher","first-page":"739016","DOI":"10.3389\/fnmol.2021.739016","volume":"14","author":"T-w Lo","year":"2021","unstructured":"Lo T-w, Figueroa-Romero C, Hur J, Pacut C, Stoll E, Spring C et al (2021) Extracellular vesicles in serum and central nervous system tissues contain microRNA signatures in sporadic amyotrophic lateral sclerosis. Front Mole Neurosci 14:739016","journal-title":"Front Mole Neurosci"},{"issue":"1","key":"5026_CR92","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1038\/s41598-023-32717-y","volume":"13","author":"J-A Kim","year":"2023","unstructured":"Kim J-A, Park C, Sung J-J, Seo D-J, Choi S-J, Hong Y-H (2023) Small RNA sequencing of circulating small extracellular vesicles microRNAs in patients with amyotrophic lateral sclerosis. Sci Rep 13(1):5528","journal-title":"Sci Rep"},{"key":"5026_CR93","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.brainres.2018.12.016","volume":"1708","author":"D Saucier","year":"2019","unstructured":"Saucier D, Wajnberg G, Roy J, Beauregard A-P, Chacko S, Crapoulet N et al (2019) Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res 1708:100\u2013108","journal-title":"Brain Res"},{"issue":"3","key":"5026_CR94","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12017-023-08744-3","volume":"25","author":"M Mohammadinasr","year":"2023","unstructured":"Mohammadinasr M, Montazersaheb S, Molavi O, Kahroba H, Talebi M, Ayromlou H et al (2023) Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers. NeuroMol Med 25(3):402\u2013414","journal-title":"NeuroMol Med"},{"issue":"4","key":"5026_CR95","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1352458517696597","volume":"24","author":"G Galazka","year":"2017","unstructured":"Galazka G, Mycko MP, Selmaj I, Raine CS, Selmaj KW (2017) Multiple sclerosis: Serum-derived exosomes express myelin proteins. Mult Scler J 24(4):449\u2013458","journal-title":"Mult Scler J"},{"issue":"5","key":"5026_CR96","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ana.24931","volume":"81","author":"I Selmaj","year":"2017","unstructured":"Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW et al (2017) Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol 81(5):703\u2013717","journal-title":"Ann Neurol"},{"issue":"8","key":"5026_CR97","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1096\/fj.201701533R","volume":"32","author":"I Manna","year":"2018","unstructured":"Manna I, Iaccino E, Dattilo V, Barone S, Vecchio E, Mimmi S et al (2018) Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients. FASEB J 32(8):4241\u20134246","journal-title":"FASEB J"},{"issue":"11","key":"5026_CR98","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/mds.28591","volume":"36","author":"C Jiang","year":"2021","unstructured":"Jiang C, Hopfner F, Berg D, Hu MT, Pilotto A, Borroni B et al (2021) Validation of \u03b1-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of parkinsonian syndromes. Mov Disord 36(11):2663\u20132669","journal-title":"Mov Disord"},{"issue":"3","key":"5026_CR99","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","volume":"142","author":"S Dutta","year":"2021","unstructured":"Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC et al (2021) \u03b1-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol 142(3):495\u2013511","journal-title":"Acta Neuropathol"},{"issue":"6","key":"5026_CR100","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","volume":"287","author":"S Saman","year":"2012","unstructured":"Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S et al (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287(6):3842\u20133849","journal-title":"J Biol Chem"},{"key":"5026_CR101","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jprot.2014.04.028","volume":"106","author":"D Chiasserini","year":"2014","unstructured":"Chiasserini D, van Weering JR, Piersma SR, Pham TV, Malekzadeh A, Teunissen CE et al (2014) Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteomics 106:191\u2013204","journal-title":"J Proteomics"},{"issue":"9","key":"5026_CR102","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/ph13090243","volume":"13","author":"I Manna","year":"2020","unstructured":"Manna I, De Benedittis S, Quattrone A, Maisano D, Iaccino E, Quattrone A (2020) Exosomal miRNAs as potential diagnostic biomarkers in Alzheimer\u2019s disease. Pharmaceuticals 13(9):243","journal-title":"Pharmaceuticals"},{"key":"5026_CR103","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnmol.2020.00038","volume":"13","author":"S Hornung","year":"2020","unstructured":"Hornung S, Dutta S, Bitan G (2020) CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci 13:38","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"5026_CR104","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-021-01174-8","volume":"18","author":"M Norman","year":"2021","unstructured":"Norman M, Ter-Ovanesyan D, Trieu W, Lazarovits R, Kowal EJ, Lee JH et al (2021) L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat Methods 18(6):631\u2013634","journal-title":"Nat Methods"},{"issue":"6","key":"5026_CR105","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","volume":"11","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB et al (2015) Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheim Dement 11(6):600\u20137. e1","journal-title":"Alzheim Dement"},{"key":"5026_CR106","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C et al (2014) Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol 128:639\u2013650","journal-title":"Acta Neuropathol"},{"key":"5026_CR107","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nbd.2018.04.015","volume":"116","author":"H Wang","year":"2018","unstructured":"Wang H, Atik A, Stewart T, Ginghina C, Aro P, Kerr KF et al (2018) Plasma \u03b1-synuclein and cognitive impairment in the Parkinson\u2019s Associated Risk Syndrome: A pilot study. Neurobiol Dis 116:53\u201359","journal-title":"Neurobiol Dis"},{"issue":"3","key":"5026_CR108","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1369\/0022155414564219","volume":"63","author":"A Zlotogorski-Hurvitz","year":"2015","unstructured":"Zlotogorski-Hurvitz A, Dayan D, Chaushu G, Korvala J, Salo T, Sormunen R et al (2015) Human saliva-derived exosomes: comparing methods of isolation. J Histochem Cytochem 63(3):181\u2013189","journal-title":"J Histochem Cytochem"},{"key":"5026_CR109","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ebiom.2019.06.021","volume":"45","author":"S Wang","year":"2019","unstructured":"Wang S, Kojima K, Mobley JA, West AB (2019) Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease. EBioMedicine 45:351\u2013361","journal-title":"EBioMedicine"},{"issue":"3","key":"5026_CR110","doi-asserted-by":"publisher","first-page":"e14677","DOI":"10.1111\/cns.14677","volume":"30","author":"W Wang","year":"2024","unstructured":"Wang W, Sun H, Duan H, Sheng G, Tian N, Liu D et al (2024) Isolation and usage of exosomes in central nervous system diseases. CNS Neurosci Ther 30(3):e14677","journal-title":"CNS Neurosci Ther"},{"key":"5026_CR111","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1007\/s12035-016-0002-4","volume":"54","author":"S Moncini","year":"2017","unstructured":"Moncini S, Lunghi M, Valmadre A, Grasso M, Del Vescovo V, Riva P et al (2017) The miR-15\/107 family of microRNA genes regulates CDK5R1\/p35 with implications for Alzheimer\u2019s disease pathogenesis. Mol Neurobiol 54:4329\u20134342","journal-title":"Mol Neurobiol"},{"key":"5026_CR112","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fphar.2018.00478","volume":"9","author":"Y Xie","year":"2018","unstructured":"Xie Y, Chu A, Feng Y, Chen L, Shao Y, Luo Q et al (2018) MicroRNA-146a: a comprehensive indicator of inflammation and oxidative stress status induced in the brain of chronic T2DM rats. Front Pharmacol 9:478","journal-title":"Front Pharmacol"},{"issue":"1","key":"5026_CR113","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2013.02.019","volume":"335","author":"M Katakowski","year":"2013","unstructured":"Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O et al (2013) Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 335(1):201\u2013204","journal-title":"Cancer Lett"},{"key":"5026_CR114","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.2147\/DDDT.S255828","volume":"14","author":"S Duan","year":"2020","unstructured":"Duan S, Wang F, Cao J, Wang C (2020) Exosomes derived from MicroRNA-146a-5p-enriched bone marrow mesenchymal stem cells alleviate intracerebral hemorrhage by inhibiting neuronal apoptosis and microglial M1 polarization. Drug Design Develop Ther 14:3143\u201358. https:\/\/doi.org\/10.2147\/DDDT.S255828","journal-title":"Drug Design Develop Ther"},{"key":"5026_CR115","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3389\/fnins.2018.00845","volume":"12","author":"D Li","year":"2018","unstructured":"Li D, Zhang P, Yao X, Li H, Shen H, Li X et al (2018) Exosomes derived from miR-133b-modified mesenchymal stem cells promote recovery after spinal cord injury. Front Neurosci 12:845","journal-title":"Front Neurosci"},{"issue":"1","key":"5026_CR116","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41467-017-02406-2","volume":"9","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hohjoh H, Fukuoka M, Sato W, Oki S, Tomi C et al (2018) Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis. Nat Commun 9(1):17","journal-title":"Nat Commun"},{"key":"5026_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-015-0349-6","volume":"14","author":"M Rebucci","year":"2015","unstructured":"Rebucci M, Sermeus A, Leonard E, Delaive E, Dieu M, Fransolet M et al (2015) miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1. Mol Cancer 14:1\u201317","journal-title":"Mol Cancer"},{"key":"5026_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-2146-x","volume":"22","author":"R Li","year":"2020","unstructured":"Li R, Zhao K, Ruan Q, Meng C, Yin F (2020) Bone marrow mesenchymal stem cell-derived exosomal microRNA-124-3p attenuates neurological damage in spinal cord ischemia-reperfusion injury by downregulating Ern1 and promoting M2 macrophage polarization. Arthritis Res Ther 22:1\u201314","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5026_CR119","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/neuonc\/nox152","volume":"20","author":"FM Lang","year":"2018","unstructured":"Lang FM, Hossain A, Gumin J, Momin EN, Shimizu Y, Ledbetter D et al (2018) Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas. Neuro Oncol 20(3):380\u2013390","journal-title":"Neuro Oncol"},{"issue":"2","key":"5026_CR120","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1159\/000490078","volume":"47","author":"M Jiang","year":"2018","unstructured":"Jiang M, Wang H, Jin M, Yang X, Ji H, Jiang Y et al (2018) Exosomes from MiR-30d-5p-ADSCs reverse acute ischemic stroke-induced, autophagy-mediated brain injury by promoting M2 microglial\/macrophage polarization. Cell Physiol Biochem 47(2):864\u2013878","journal-title":"Cell Physiol Biochem"},{"issue":"19","key":"5026_CR121","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1093\/hmg\/ddn201","volume":"17","author":"N Mellios","year":"2008","unstructured":"Mellios N, Huang H-S, Grigorenko A, Rogaev E, Akbarian S (2008) A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 17(19):3030\u20133042","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5026_CR122","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1161\/STROKEAHA.116.015204","volume":"48","author":"H Xin","year":"2017","unstructured":"Xin H, Katakowski M, Wang F, Qian J-Y, Liu XS, Ali MM et al (2017) MicroRNA-17\u201392 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats. Stroke 48(3):747\u2013753","journal-title":"Stroke"},{"issue":"12","key":"5026_CR123","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/jcbfm.2015.156","volume":"35","author":"Y Wang","year":"2015","unstructured":"Wang Y, Huang J, Ma Y, Tang G, Liu Y, Chen X et al (2015) MicroRNA-29b is a therapeutic target in cerebral ischemia associated with aquaporin 4. J Cereb Blood Flow Metab 35(12):1977\u20131984","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"5026_CR124","doi-asserted-by":"publisher","first-page":"108946","DOI":"10.1016\/j.celrep.2021.108946","volume":"35","author":"V Swahari","year":"2021","unstructured":"Swahari V, Nakamura A, Hollville E, Stroud H, Simon JM, Ptacek TS et al (2021) MicroRNA-29 is an essential regulator of brain maturation through regulation of CH methylation. Cell Reports 35(1):108946. https:\/\/doi.org\/10.1016\/j.celrep.2021.108946","journal-title":"Cell Reports"},{"issue":"8","key":"5026_CR125","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jcbfm.2013.68","volume":"33","author":"S Khanna","year":"2013","unstructured":"Khanna S, Rink C, Ghoorkhanian R, Gnyawali S, Heigel M, Wijesinghe DS et al (2013) Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. J Cereb Blood Flow Metab 33(8):1197\u20131206","journal-title":"J Cereb Blood Flow Metab"},{"key":"5026_CR126","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10571-016-0338-3","volume":"36","author":"F Wei","year":"2016","unstructured":"Wei F, Wang Q, Su Q, Huang H, Luan J, Xu X et al (2016) miR-373 inhibits glioma cell U251 migration and invasion by down-regulating CD44 and TGFBR2. Cell Mol Neurobiol 36:1389\u20131397","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"5026_CR127","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3892\/etm.2016.3021","volume":"11","author":"X-J Tang","year":"2016","unstructured":"Tang X-J, Yang M-H, Cao G, Lu J-T, Luo J, Dai L-J et al (2016) Protective effect of microRNA-138 against cerebral ischemia\/reperfusion injury in rats. Exp Ther Med 11(3):1045\u20131050","journal-title":"Exp Ther Med"},{"key":"5026_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13036-019-0193-0","volume":"13","author":"Y Deng","year":"2019","unstructured":"Deng Y, Chen D, Gao F, Lv H, Zhang G, Sun X et al (2019) Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2. J Biol Eng 13:1\u201318","journal-title":"J Biol Eng"},{"issue":"5","key":"5026_CR129","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41419-020-2530-0","volume":"11","author":"X Gao","year":"2020","unstructured":"Gao X, Xiong Y, Li Q, Han M, Shan D, Yang G et al (2020) Extracellular vesicle-mediated transfer of miR-21-5p from mesenchymal stromal cells to neurons alleviates early brain injury to improve cognitive function via the PTEN\/Akt pathway after subarachnoid hemorrhage. Cell Death Dis 11(5):363","journal-title":"Cell Death Dis"},{"key":"5026_CR130","doi-asserted-by":"publisher","first-page":"108818","DOI":"10.1016\/j.biopha.2019.108818","volume":"115","author":"X Zhou","year":"2019","unstructured":"Zhou X, Chu X, Yuan H, Qiu J, Zhao C, Xin D et al (2019) Mesenchymal stem cell derived EVs mediate neuroprotection after spinal cord injury in rats via the microRNA-21-5p\/FasL gene axis. Biomed Pharmacother 115:108818","journal-title":"Biomed Pharmacother"},{"key":"5026_CR131","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13402-017-0355-3","volume":"41","author":"F Lan","year":"2018","unstructured":"Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X (2018) Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma. Cell Oncol 41:25\u201333","journal-title":"Cell Oncol"},{"key":"5026_CR132","doi-asserted-by":"publisher","first-page":"101321","DOI":"10.1016\/j.arr.2021.101321","volume":"68","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma S, Lv J, Wang X, Afewerky HK, Li H et al (2021) The emerging role of exosomes in Alzheimer\u2019s disease. Ageing Res Rev 68:101321","journal-title":"Ageing Res Rev"},{"issue":"4","key":"5026_CR133","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan R, Reddy PH (2017) Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J Alzheimers Dis 57(4):975\u2013999","journal-title":"J Alzheimers Dis"},{"key":"5026_CR134","unstructured":"Kumar A, Sidhu J, Lui F, Tsao JW, Doerr C (2025) Alzheimer Disease (Nursing). StatPearls Publishing, Treasure Island (FL). http:\/\/europepmc.org\/abstract\/MED\/33760564"},{"key":"5026_CR135","doi-asserted-by":"publisher","first-page":"102113","DOI":"10.1016\/j.arr.2023.102113","volume":"92","author":"T Khan","year":"2023","unstructured":"Khan T, Waseem R, Shahid M, Ansari J, Ahanger IA, Hassan I et al (2023) Recent advancement in therapeutic strategies for Alzheimer\u2019s disease: Insights from clinical trials. Ageing Res Rev 92:102113","journal-title":"Ageing Res Rev"},{"key":"5026_CR136","doi-asserted-by":"publisher","first-page":"111175","DOI":"10.1016\/j.mad.2019.111175","volume":"184","author":"T-R Li","year":"2019","unstructured":"Li T-R, Wang X-N, Sheng C, Li Y-X, Li FZ-T, Sun Y et al (2019) Extracellular vesicles as an emerging tool for the early detection of Alzheimer\u2019s disease. Mechanisms of ageing and development 184:111175","journal-title":"Mechanisms of ageing and development"},{"key":"5026_CR137","doi-asserted-by":"publisher","first-page":"112365","DOI":"10.1016\/j.msec.2021.112365","volume":"129","author":"Q Huo","year":"2021","unstructured":"Huo Q, Shi Y, Qi Y, Huang L, Sui H, Zhao L (2021) Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of A\u03b2 aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer\u2019s disease. Mater Sci Eng, C 129:112365","journal-title":"Mater Sci Eng, C"},{"issue":"1","key":"5026_CR138","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/10717544.2020.1762262","volume":"27","author":"Y Qi","year":"2020","unstructured":"Qi Y, Guo L, Jiang Y, Shi Y, Sui H, Zhao L (2020) Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Delivery 27(1):745\u2013755","journal-title":"Drug Delivery"},{"issue":"6","key":"5026_CR139","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/biomedicines9060594","volume":"9","author":"Y-A Chen","year":"2021","unstructured":"Chen Y-A, Lu C-H, Ke C-C, Chiu S-J, Jeng F-S, Chang C-W et al (2021) Mesenchymal stem cell-derived exosomes ameliorate Alzheimer\u2019s disease pathology and improve cognitive deficits. Biomedicines 9(6):594","journal-title":"Biomedicines"},{"issue":"1","key":"5026_CR140","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12974-022-02393-2","volume":"19","author":"S Liu","year":"2022","unstructured":"Liu S, Fan M, Xu J-X, Yang L-J, Qi C-C, Xia Q-R et al (2022) Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology. J Neuroinflammation 19(1):35","journal-title":"J Neuroinflammation"},{"issue":"10","key":"5026_CR141","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/1061186X.2021.1929257","volume":"29","author":"Y Yu","year":"2021","unstructured":"Yu Y, Li W, Mao L, Peng W, Long D, Li D et al (2021) Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer\u2019s disease. J Drug Target 29(10):1128\u20131138","journal-title":"J Drug Target"},{"key":"5026_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-019-0150-2","volume":"16","author":"G-h Cui","year":"2019","unstructured":"Cui G-h, Guo H-d, Li H, Zhai Y, Gong Z-b, Wu J et al (2019) RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer\u2019s disease. Immuni & Ageing 16:1\u201312","journal-title":"Immuni & Ageing"},{"issue":"15","key":"5026_CR143","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1111\/jcmm.16787","volume":"25","author":"L Zhai","year":"2021","unstructured":"Zhai L, Shen H, Sheng Y, Guan Q (2021) ADMSC Exo-MicroRNA-22 improve neurological function and neuroinflammation in mice with Alzheimer\u2019s disease. J Cell Mol Med 25(15):7513\u20137523","journal-title":"J Cell Mol Med"},{"key":"5026_CR144","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.bbih.2020.100149","volume":"9","author":"M Nakano","year":"2020","unstructured":"Nakano M, Kubota K, Hashizume S, Kobayashi E, Chikenji TS, Saito Y et al (2020) An enriched environment prevents cognitive impairment in an Alzheimer\u2019s disease model by enhancing the secretion of exosomal microRNA-146a from the choroid plexus. Brain, behavior, & immunity-health 9:100149","journal-title":"Brain, behavior, & immunity-health"},{"key":"5026_CR145","doi-asserted-by":"publisher","first-page":"102410","DOI":"10.1016\/j.arr.2024.102410","volume":"99","author":"A Reddy","year":"2024","unstructured":"Reddy A, Reddy RP, Roghani AK, Garcia RI, Khemka S, Pattoor V et al (2024) Artificial intelligence in Parkinson\u2019s disease: early detection and diagnostic advancements. Ageing Res Rev 99:102410. https:\/\/doi.org\/10.1016\/j.arr.2024.102410","journal-title":"Ageing Res Rev"},{"key":"5026_CR146","doi-asserted-by":"publisher","first-page":"113525","DOI":"10.1016\/j.expneurol.2020.113525","volume":"336","author":"X-L Si","year":"2021","unstructured":"Si X-L, Fang Y-J, Li L-F, Gu L-Y, Yin X-Z, Yan Y-P et al (2021) From inflammasome to Parkinson\u2019s disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson\u2019s disease? Exp Neurol 336:113525","journal-title":"Exp Neurol"},{"issue":"3","key":"5026_CR147","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jnc.15288","volume":"157","author":"JR Pinnell","year":"2021","unstructured":"Pinnell JR, Cui M, Tieu K (2021) Exosomes in Parkinson disease. J Neurochem 157(3):413\u2013428","journal-title":"J Neurochem"},{"key":"5026_CR148","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neulet.2013.06.009","volume":"548","author":"C Chang","year":"2013","unstructured":"Chang C, Lang H, Geng N, Wang J, Li N, Wang X (2013) Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD. Neurosci Lett 548:190\u2013195","journal-title":"Neurosci Lett"},{"key":"5026_CR149","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nbd.2015.03.003","volume":"85","author":"D Br\u00fcck","year":"2016","unstructured":"Br\u00fcck D, Wenning GK, Stefanova N, Fellner L (2016) Glia and alpha-synuclein in neurodegeneration: A complex interaction. Neurobiol Dis 85:262\u2013274","journal-title":"Neurobiol Dis"},{"issue":"10","key":"5026_CR150","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3390\/ijms20102373","volume":"20","author":"A Picca","year":"2019","unstructured":"Picca A, Guerra F, Calvani R, Bucci C, Lo Monaco MR, Bentivoglio AR et al (2019) Mitochondrial-derived vesicles as candidate biomarkers in Parkinson\u2019s disease: Rationale, design and methods of the EXosomes in PArkiNson Disease (EXPAND) study. Int J Mol Sci 20(10):2373","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5026_CR151","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-0854.2007.00677.x","volume":"9","author":"CM Fader","year":"2008","unstructured":"Fader CM, S\u00e1nchez D, Furl\u00e1n M, Colombo MI (2008) Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic 9(2):230\u2013250","journal-title":"Traffic"},{"issue":"2","key":"5026_CR152","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/JAD-220575","volume":"90","author":"XA Alvarez","year":"2022","unstructured":"Alvarez XA, Winston CN, Barlow JW, Sarsoza FM, Alvarez I, Aleixandre M et al (2022) Modulation of amyloid-\u03b2 and tau in Alzheimer\u2019s disease plasma neuronal-derived extracellular vesicles by cerebrolysin\u00ae and donepezil. J Alzheimers Dis 90(2):705\u2013717","journal-title":"J Alzheimers Dis"},{"key":"5026_CR153","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","volume":"313","author":"SWL Lee","year":"2019","unstructured":"Lee SWL, Paoletti C, Campisi M, Osaki T, Adriani G, Kamm RD et al (2019) MicroRNA delivery through nanoparticles. J Control Release 313:80\u201395","journal-title":"J Control Release"},{"key":"5026_CR154","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","volume":"644","author":"X-Y Cao","year":"2017","unstructured":"Cao X-Y, Lu J-M, Zhao Z-Q, Li M-C, Lu T, An X-S et al (2017) MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles. Neurosci Lett 644:94\u201399","journal-title":"Neurosci Lett"},{"key":"5026_CR155","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","volume":"287","author":"M Qu","year":"2018","unstructured":"Qu M, Lin Q, Huang L, Fu Y, Wang L, He S et al (2018) Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson\u2019s disease. J Control Release 287:156\u2013166","journal-title":"J Control Release"},{"issue":"17","key":"5026_CR156","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1021\/acs.jafc.0c07658","volume":"69","author":"S Luo","year":"2021","unstructured":"Luo S, Sun X, Huang M, Ma Q, Du L, Cui Y (2021) Enhanced neuroprotective effects of epicatechin gallate encapsulated by bovine milk-derived exosomes against Parkinson\u2019s disease through antiapoptosis and antimitophagy. J Agric Food Chem 69(17):5134\u20135143","journal-title":"J Agric Food Chem"},{"issue":"12","key":"5026_CR157","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/mds.25978","volume":"29","author":"JM Cooper","year":"2014","unstructured":"Cooper JM, Wiklander PO, Nordin JZ, Al-Shawi R, Wood MJ, Vithlani M et al (2014) Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord 29(12):1476\u20131485","journal-title":"Mov Disord"},{"key":"5026_CR158","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.omtn.2019.07.008","volume":"17","author":"X Ren","year":"2019","unstructured":"Ren X, Zhao Y, Xue F, Zheng Y, Huang H, Wang W et al (2019) Exosomal DNA aptamer targeting \u03b1-synuclein aggregates reduced neuropathological deficits in a mouse Parkinson\u2019s disease model. Molecular Therapy-Nucleic Acids 17:726\u2013740","journal-title":"Molecular Therapy-Nucleic Acids"},{"issue":"50","key":"5026_CR159","doi-asserted-by":"publisher","first-page":"eaba3967","DOI":"10.1126\/sciadv.aba3967","volume":"6","author":"L Liu","year":"2020","unstructured":"Liu L, Li Y, Peng H, Liu R, Ji W, Shi Z et al (2020) Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson\u2019s disease. Sci Adv 6(50):eaba3967","journal-title":"Sci Adv"},{"issue":"4","key":"5026_CR160","doi-asserted-by":"publisher","first-page":"1700611","DOI":"10.1002\/advs.201700611","volume":"5","author":"Y Lin","year":"2018","unstructured":"Lin Y, Wu J, Gu W, Huang Y, Tong Z, Huang L et al (2018) Exosome\u2013liposome hybrid nanoparticles deliver CRISPR\/Cas9 system in MSCs. Advanced Science 5(4):1700611","journal-title":"Advanced Science"},{"key":"5026_CR161","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z et al (2015) Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release 207:18\u201330","journal-title":"J Control Release"},{"key":"5026_CR162","doi-asserted-by":"publisher","first-page":"950715","DOI":"10.3389\/fneur.2022.950715","volume":"13","author":"S-f Liu","year":"2022","unstructured":"Liu S-f, Li L-y, Zhuang J-l, Li M-m, Ye L-c, Chen X-r et al (2022) Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson\u2019s disease: a systematic review. Front Neurol 13:950715","journal-title":"Front Neurol"},{"issue":"4","key":"5026_CR163","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/sctm.19-0174","volume":"9","author":"S-Y Chen","year":"2020","unstructured":"Chen S-Y, Lin M-c, Tsai J-S, He P-L, Luo W-T, Chiu I-M et al (2020) Exosomal 2\u2032, 3\u2032-CNP from mesenchymal stem cells promotes hippocampus CA1 neurogenesis\/neuritogenesis and contributes to rescue of cognition\/learning deficiencies of damaged brain. Stem Cells Trans Med 9(4):499\u2013517","journal-title":"Stem Cells Trans Med"},{"key":"5026_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1177-1","volume":"10","author":"J Jin","year":"2019","unstructured":"Jin J, Shi Y, Gong J, Zhao L, Li Y, He Q et al (2019) Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther 10:1\u201315","journal-title":"Stem Cell Res Ther"},{"key":"5026_CR165","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00415-018-8940-6","volume":"266","author":"S Podvin","year":"2019","unstructured":"Podvin S, Reardon HT, Yin K, Mosier C, Hook V (2019) Multiple clinical features of Huntington\u2019s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration. J Neurol 266:551\u2013564","journal-title":"J Neurol"},{"issue":"2","key":"5026_CR166","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ncb1830","volume":"11","author":"P-H Ren","year":"2009","unstructured":"Ren P-H, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11(2):219\u2013225","journal-title":"Nat Cell Biol"},{"issue":"8","key":"5026_CR167","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nn.3761","volume":"17","author":"E Pecho-Vrieseling","year":"2014","unstructured":"Pecho-Vrieseling E, Rieker C, Fuchs S, Bleckmann D, Esposito MS, Botta P et al (2014) Transneuronal propagation of mutant huntingtin contributes to non\u2013cell autonomous pathology in neurons. Nat Neurosci 17(8):1064\u20131072","journal-title":"Nat Neurosci"},{"issue":"1","key":"5026_CR168","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ana.24174","volume":"76","author":"F Cicchetti","year":"2014","unstructured":"Cicchetti F, Lacroix S, Cisbani G, Valli\u00e8res N, Saint-Pierre M, St-Amour I et al (2014) Mutant huntingtin is present in neuronal grafts in Huntington disease patients. Ann Neurol 76(1):31\u201342","journal-title":"Ann Neurol"},{"key":"5026_CR169","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10571-016-0350-7","volume":"36","author":"X Zhang","year":"2016","unstructured":"Zhang X, Abels ER, Redzic JS, Margulis J, Finkbeiner S, Breakefield XO (2016) Potential transfer of polyglutamine and CAG-repeat RNA in extracellular vesicles in Huntington\u2019s disease: background and evaluation in cell culture. Cell Mol Neurobiol 36:459\u2013470","journal-title":"Cell Mol Neurobiol"},{"issue":"39","key":"5026_CR170","doi-asserted-by":"publisher","first-page":"9550","DOI":"10.1523\/JNEUROSCI.1418-17.2017","volume":"37","author":"Y Hong","year":"2017","unstructured":"Hong Y, Zhao T, Li X-J, Li S (2017) Mutant huntingtin inhibits \u03b1B-crystallin expression and impairs exosome secretion from astrocytes. J Neurosci 37(39):9550\u20139563","journal-title":"J Neurosci"},{"issue":"4","key":"5026_CR171","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1111\/ejn.13275","volume":"44","author":"M Lee","year":"2016","unstructured":"Lee M, Liu T, Im W, Kim M (2016) Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington\u2019s disease in vitro model. Eur J Neurosci 44(4):2114\u20132119","journal-title":"Eur J Neurosci"},{"issue":"1","key":"5026_CR172","doi-asserted-by":"publisher","first-page":"657086","DOI":"10.1155\/2015\/657086","volume":"2015","author":"J Lin","year":"2015","unstructured":"Lin J, Li J, Huang B, Liu J, Chen X, Chen X-M et al (2015) Exosomes: novel biomarkers for clinical diagnosis. Scientific World Journal 2015(1):657086","journal-title":"Scientific World Journal"},{"key":"5026_CR173","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1007\/s00415-018-9022-5","volume":"265","author":"HL Denis","year":"2018","unstructured":"Denis HL, Lamontagne-Proulx J, St-Amour I, Mason SL, Weiss A, Chouinard S et al (2018) Platelet-derived extracellular vesicles in Huntington\u2019s disease. J Neurol 265:2704\u20132712","journal-title":"J Neurol"},{"issue":"3","key":"5026_CR174","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/jnnp-2018-318854","volume":"90","author":"HL Denis","year":"2019","unstructured":"Denis HL, Lamontagne-Proulx J, St-Amour I, Mason SL, Rowley JW, Cloutier N et al (2019) Platelet abnormalities in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 90(3):272\u2013283","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"40","key":"5026_CR175","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.2174\/1381612823666170913164738","volume":"23","author":"J Matsumoto","year":"2017","unstructured":"Matsumoto J, Stewart T, Banks WA, Zhang J (2017) The transport mechanism of extracellular vesicles at the blood-brain barrier. Curr Pharm Des 23(40):6206\u20136214","journal-title":"Curr Pharm Des"},{"issue":"1","key":"5026_CR176","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/ijms22010138","volume":"22","author":"A Kumar","year":"2020","unstructured":"Kumar A, Zhou L, Zhi K, Raji B, Pernell S, Tadrous E et al (2020) Challenges in biomaterial-based drug delivery approach for the treatment of neurodegenerative diseases: Opportunities for extracellular vesicles. Int J Mol Sci 22(1):138","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5026_CR177","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14802\/jmd.16054","volume":"10","author":"S-T Lee","year":"2017","unstructured":"Lee S-T, Im W, Ban J-J, Lee M, Jung K-H, Lee SK et al (2017) Exosome-based delivery of miR-124 in a Huntington\u2019s disease model. Journal of movement disorders 10(1):45","journal-title":"Journal of movement disorders"},{"issue":"5","key":"5026_CR178","first-page":"327","volume":"17","author":"B Ridolfi","year":"2017","unstructured":"Ridolfi B, Abdel-Haq H (2017) Neurodegenerative disorders treatment: the MicroRNA role. Curr Gene Ther 17(5):327\u2013363","journal-title":"Curr Gene Ther"},{"issue":"Suppl 1","key":"5026_CR179","first-page":"A88","volume":"89","author":"T Wu","year":"2018","unstructured":"Wu T, Yu M, Zhang L, Chen X, Pei Z (2018) I02 Systemic injection of exosomal sirna significantly reduced huntingtin expression in transgenic mice of huntington\u2019s disease. J Neurol Neurosurg Psychiatry 89(Suppl 1):A88\u2013A89","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"5026_CR180","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/mt.2016.126","volume":"24","author":"M-C Didiot","year":"2016","unstructured":"Didiot M-C, Hall LM, Coles AH, Haraszti RA, Godinho BM, Chase K et al (2016) Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol Ther 24(10):1836\u20131847","journal-title":"Mol Ther"},{"issue":"10","key":"5026_CR181","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/jnnp.2009.201251","volume":"81","author":"FJ Mateen","year":"2010","unstructured":"Mateen FJ, Carone M, Sorenson EJ (2010) Patients who survive 5 years or more with ALS in Olmsted County, 1925\u20132004. J Neurol Neurosurg Psychiatry 81(10):1144\u20131146","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5\u20136","key":"5026_CR182","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3109\/21678421.2014.903974","volume":"15","author":"S Paganoni","year":"2014","unstructured":"Paganoni S, Macklin EA, Lee A, Murphy A, Chang J, Zipf A et al (2014) Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15(5\u20136):453\u2013456","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"4","key":"5026_CR183","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ncl.2015.07.001","volume":"33","author":"K Boylan","year":"2015","unstructured":"Boylan K (2015) Familial amyotrophic lateral sclerosis. Neurol Clin 33(4):807\u2013830","journal-title":"Neurol Clin"},{"issue":"6415","key":"5026_CR184","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A et al (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59\u201362","journal-title":"Nature"},{"issue":"3","key":"5026_CR185","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602\u2013611","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"5026_CR186","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","volume":"11","author":"E Majounie","year":"2012","unstructured":"Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. The Lancet Neurology 11(4):323\u2013330","journal-title":"The Lancet Neurology"},{"issue":"22","key":"5026_CR187","doi-asserted-by":"publisher","first-page":"15699","DOI":"10.1074\/jbc.M112.425066","volume":"288","author":"M Basso","year":"2013","unstructured":"Basso M, Pozzi S, Tortarolo M, Fiordaliso F, Bisighini C, Pasetto L et al (2013) Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem 288(22):15699\u201315711","journal-title":"J Biol Chem"},{"issue":"5918","key":"5026_CR188","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"T Kwiatkowski Jr","year":"2009","unstructured":"Kwiatkowski T Jr, Bosco D, Leclerc A, Tamrazian E, Vanderburg C, Russ C et al (2009) Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323(5918):1205\u20131208","journal-title":"Science"},{"issue":"6125","key":"5026_CR189","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.1232927","volume":"339","author":"K Mori","year":"2013","unstructured":"Mori K, Weng S-M, Arzberger T, May S, Rentzsch K, Kremmer E et al (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS. Science 339(6125):1335\u20131338","journal-title":"Science"},{"issue":"2","key":"5026_CR190","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215\u201333","journal-title":"Cell"},{"key":"5026_CR191","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","volume":"15","author":"B De Felice","year":"2014","unstructured":"De Felice B, Annunziata A, Fiorentino G, Borra M, Biffali E, Coppola C et al (2014) miR-338\u20133p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics 15:243\u201353","journal-title":"Neurogenetics"},{"key":"5026_CR192","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.03.027","volume":"55","author":"R Waller","year":"2017","unstructured":"Waller R, Goodall EF, Milo M, Cooper-Knock J, Da Costa M, Hobson E et al (2017) Serum miRNAs miR-206, 143\u20133p and 374b\u20135p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Neurobiol Aging 55:123\u2013131","journal-title":"Neurobiol Aging"},{"key":"5026_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2051-5960-1-42","volume":"1","author":"A Freischmidt","year":"2013","unstructured":"Freischmidt A, M\u00fcller K, Ludolph AC, Weishaupt JH (2013) Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol Commun 1:1\u20139","journal-title":"Acta Neuropathol Commun"},{"key":"5026_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-6606-6-31","volume":"6","author":"Y Nishimoto","year":"2013","unstructured":"Nishimoto Y, Nakagawa S, Hirose T, Okano HJ, Takao M, Shibata S et al (2013) The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol Brain 6:1\u201318","journal-title":"Mol Brain"},{"key":"5026_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0658-x","volume":"7","author":"H An","year":"2019","unstructured":"An H, Skelt L, Notaro A, Highley JR, Fox AH, La Bella V et al (2019) ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol Commun 7:1\u201314","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"5026_CR196","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1038\/s41598-018-20679-5","volume":"8","author":"S Gagliardi","year":"2018","unstructured":"Gagliardi S, Zucca S, Pandini C, Diamanti L, Bordoni M, Sproviero D et al (2018) Long non-coding and coding RNAs characterization in peripheral blood mononuclear cells and spinal cord from amyotrophic lateral sclerosis patients. Sci Rep 8(1):2378","journal-title":"Sci Rep"},{"issue":"3","key":"5026_CR197","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP (2017) Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain 140(3):527\u2013546","journal-title":"Brain"},{"issue":"3","key":"5026_CR198","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1039\/D1BM01142A","volume":"10","author":"X-Y Wu","year":"2022","unstructured":"Wu X-Y, Liao B-Y, Xiao D, Wu W-C, Xiao Y, Alexander T et al (2022) Encapsulation of bryostatin-1 by targeted exosomes enhances remyelination and neuroprotection effects in the cuprizone-induced demyelinating animal model of multiple sclerosis. Biomaterials Science 10(3):714\u2013727","journal-title":"Biomaterials Science"},{"key":"5026_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.02.015","volume":"318","author":"F Chu","year":"2018","unstructured":"Chu F, Shi M, Zheng C, Shen D, Zhu J, Zheng X et al (2018) The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 318:1\u20137","journal-title":"J Neuroimmunol"},{"key":"5026_CR200","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jconrel.2022.12.026","volume":"353","author":"X Zheng","year":"2023","unstructured":"Zheng X, Sun K, Liu Y, Yin X, Zhu H, Yu F et al (2023) Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia. J Control Release 353:675\u2013684","journal-title":"J Control Release"},{"key":"5026_CR201","doi-asserted-by":"publisher","first-page":"175628642110076","DOI":"10.1177\/17562864211007687","volume":"14","author":"S Haase","year":"2021","unstructured":"Haase S, Linker RA (2021) Inflammation in multiple sclerosis. Ther Adv Neurol Disord 14:17562864211007688","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"5026_CR202","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","volume":"13","author":"M Riazifar","year":"2019","unstructured":"Riazifar M, Mohammadi MR, Pone EJ, Yeri A, Lasser C, Segaliny AI et al (2019) Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano 13(6):6670\u20136688","journal-title":"ACS Nano"},{"issue":"27","key":"5026_CR203","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.2174\/092986711797189600","volume":"18","author":"X Ni","year":"2011","unstructured":"Ni X, Castanares M, Mukherjee A, Lupold SE (2011) Nucleic acid aptamers: clinical applications and promising new horizons. Curr Med Chem 18(27):4206\u20134214","journal-title":"Curr Med Chem"},{"key":"5026_CR204","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2019.02.032","volume":"299","author":"FH Shamili","year":"2019","unstructured":"Shamili FH, Alibolandi M, Rafatpanah H, Abnous K, Mahmoudi M, Kalantari M et al (2019) Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score. J Control Release 299:149\u2013164","journal-title":"J Control Release"},{"issue":"15","key":"5026_CR205","doi-asserted-by":"publisher","first-page":"8505","DOI":"10.1039\/D1RA00550B","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang Q, Cheng S, Qin F, Fu A, Fu C (2021) Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system. RSC Adv 11(15):8505\u20138515","journal-title":"RSC Adv"},{"issue":"19","key":"5026_CR206","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1039\/D2BM00518B","volume":"10","author":"Y Zhai","year":"2022","unstructured":"Zhai Y, Wang Q, Zhu Z, Hao Y, Han F, Hong J et al (2022) High-efficiency brain-targeted intranasal delivery of BDNF mediated by engineered exosomes to promote remyelination. Biomaterials science 10(19):5707\u20135718","journal-title":"Biomaterials science"},{"issue":"11","key":"5026_CR207","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1089\/wound.2024.0093","volume":"13","author":"A Yadav","year":"2024","unstructured":"Yadav A, Xuan Y, Sen CK, Ghatak S (2024) Standardized reporting of research on exosomes to ensure rigor and reproducibility. Adv Wound Care 13(11):584\u2013599","journal-title":"Adv Wound Care"},{"key":"5026_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-018-0433-3","volume":"17","author":"J Lim","year":"2019","unstructured":"Lim J, Choi M, Lee H, Kim Y-H, Han J-Y, Lee ES et al (2019) Direct isolation and characterization of circulating exosomes from biological samples using magnetic nanowires. Journal of nanobiotechnology 17:1\u201312","journal-title":"Journal of nanobiotechnology"},{"issue":"7","key":"5026_CR209","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1021\/acsnano.7b00549","volume":"11","author":"SD Ibsen","year":"2017","unstructured":"Ibsen SD, Wright J, Lewis JM, Kim S, Ko S-Y, Ong J et al (2017) Rapid isolation and detection of exosomes and associated biomarkers from plasma. ACS Nano 11(7):6641\u20136651","journal-title":"ACS Nano"},{"issue":"9","key":"5026_CR210","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.3390\/cells9091955","volume":"9","author":"F Royo","year":"2020","unstructured":"Royo F, Th\u00e9ry C, Falc\u00f3n-P\u00e9rez JM, Nieuwland R, Witwer KW (2020) Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee. Cells 9(9):1955","journal-title":"Cells"},{"issue":"23\u201324","key":"5026_CR211","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1002\/elps.201800526","volume":"40","author":"S Ayala-Mar","year":"2019","unstructured":"Ayala-Mar S, Donoso-Quezada J, Gallo-Villanueva RC, Perez-Gonzalez VH, Gonz\u00e1lez-Valdez J (2019) Recent advances and challenges in the recovery and purification of cellular exosomes. Electrophoresis 40(23\u201324):3036\u20133049","journal-title":"Electrophoresis"},{"key":"5026_CR212","doi-asserted-by":"publisher","first-page":"100062","DOI":"10.1016\/j.bionps.2023.100062","volume":"8","author":"M Luebke","year":"2023","unstructured":"Luebke M, Parulekar M, Thomas FP (2023) Fluid biomarkers for the diagnosis of neurodegenerative diseases. Biomarkers in Neuropsychiatry 8:100062","journal-title":"Biomarkers in Neuropsychiatry"},{"issue":"6","key":"5026_CR213","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J Intern Med 284(6):643\u2013663","journal-title":"J Intern Med"},{"key":"5026_CR214","doi-asserted-by":"crossref","unstructured":"Fraser KB, Moehle MS, Alcalay RN, West AB, Consortium LC, Bressman S, et al (2016) Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers. Neurology 86(11):994\u20139.","DOI":"10.1212\/WNL.0000000000002436"},{"issue":"1","key":"5026_CR215","doi-asserted-by":"publisher","first-page":"26901","DOI":"10.3402\/jev.v4.26901","volume":"4","author":"C Gardiner","year":"2015","unstructured":"Gardiner C, Harrison P, Belting M, B\u00f6ing A, Campello E, Carter BS et al (2015) Extracellular vesicles, tissue factor, cancer and thrombosis\u2013discussion themes of the ISEV 2014 Educational Day. Journal of extracellular vesicles 4(1):26901","journal-title":"Journal of extracellular vesicles"},{"issue":"3","key":"5026_CR216","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf RM (2018) Biomarker definitions and their applications. Exp Biol Med 243(3):213\u2013221","journal-title":"Exp Biol Med"},{"issue":"35","key":"5026_CR217","doi-asserted-by":"publisher","first-page":"56279","DOI":"10.18632\/oncotarget.10783","volume":"7","author":"M-R Muhsin-Sharafaldine","year":"2016","unstructured":"Muhsin-Sharafaldine M-R, Saunderson SC, Dunn AC, Faed JM, Kleffmann T, McLellan AD (2016) Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget 7(35):56279","journal-title":"Oncotarget"},{"issue":"8","key":"5026_CR218","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/icb.2010.64","volume":"88","author":"SI Buschow","year":"2010","unstructured":"Buschow SI, Van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W (2010) MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol 88(8):851\u2013856","journal-title":"Immunol Cell Biol"},{"key":"5026_CR219","doi-asserted-by":"publisher","first-page":"147421","DOI":"10.1016\/j.cej.2023.147421","volume":"479","author":"M Yang","year":"2024","unstructured":"Yang M, Pu L, Yang S, Chen Z, Guo J, Liu Y et al (2024) Engineered antler stem cells derived exosomes potentiate anti-tumor efficacy of immune checkpoint inhibitor by reprogramming immunosuppressive tumor microenvironment. Chem Eng J 479:147421","journal-title":"Chem Eng J"},{"key":"5026_CR220","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fphys.2012.00229","volume":"3","author":"V Vingtdeux","year":"2012","unstructured":"Vingtdeux V, Sergeant N, Bu\u00e9e L (2012) Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer\u2019s disease. Front Physiol 3:229","journal-title":"Front Physiol"},{"issue":"2","key":"5026_CR221","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4103\/1673-5374.317975","volume":"17","author":"Z Ruan","year":"2022","unstructured":"Ruan Z (2022) Extracellular vesicles drive tau spreading in Alzheimer\u2019s disease. Neural Regen Res 17(2):328\u2013329","journal-title":"Neural Regen Res"},{"key":"5026_CR222","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcdb.2015.02.007","volume":"40","author":"BM Coleman","year":"2015","unstructured":"Coleman BM, Hill AF (2015) Extracellular vesicles\u2013Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases. Sem Cell Develop Biol Elsevier 40:89\u201396. https:\/\/doi.org\/10.1016\/j.semcdb.2015.02.007","journal-title":"Sem Cell Develop Biol Elsevier"},{"issue":"1","key":"5026_CR223","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"5026_CR224","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jbiotec.2013.03.013","volume":"165","author":"Y Takahashi","year":"2013","unstructured":"Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T et al (2013) Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol 165(2):77\u201384","journal-title":"J Biotechnol"},{"key":"5026_CR225","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2021.01.001","volume":"31","author":"N Parada","year":"2021","unstructured":"Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F (2021) Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res 31:61\u201374","journal-title":"J Adv Res"},{"key":"5026_CR226","doi-asserted-by":"publisher","first-page":"1429442","DOI":"10.3389\/fimmu.2024.1429442","volume":"15","author":"KA Shahzad","year":"2024","unstructured":"Shahzad KA, Wang Z, Li X, Li J, Xu M, Tan F (2024) Immunomodulatory effect of PLGA-encapsulated mesenchymal stem cells-derived exosomes for the treatment of allergic rhinitis. Front Immunol 15:1429442. https:\/\/doi.org\/10.3389\/fimmu.2024.1429442","journal-title":"Front Immunol"},{"issue":"5","key":"5026_CR227","first-page":"744","volume":"8","author":"EV Batrakova","year":"2016","unstructured":"Batrakova EV, Kim MS (2016) Development and regulation of exosome-based therapy products. Wiley Interdiscipli Rev: Nanomed Nanobiotechnol 8(5):744\u2013757","journal-title":"Wiley Interdiscipli Rev: Nanomed Nanobiotechnol"},{"issue":"6","key":"5026_CR228","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D (2017) Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38(6):754\u2013763","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"5026_CR229","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/10717544.2020.1748758","volume":"27","author":"W Meng","year":"2020","unstructured":"Meng W, He C, Hao Y, Wang L, Li L, Zhu G (2020) Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Drug Delivery 27(1):585\u2013598","journal-title":"Drug Delivery"},{"issue":"1","key":"5026_CR230","doi-asserted-by":"publisher","first-page":"011503","DOI":"10.1063\/1.5087122","volume":"3","author":"X Li","year":"2019","unstructured":"Li X, Corbett AL, Taatizadeh E, Tasnim N, Little JP, Garnis C et al (2019) Challenges and opportunities in exosome research\u2014Perspectives from biology, engineering, and cancer therapy. APL Bioeng 3(1):011503. https:\/\/doi.org\/10.1063\/1.5087122","journal-title":"APL Bioeng"},{"issue":"19","key":"5026_CR231","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.3390\/ijms20194684","volume":"20","author":"N Ludwig","year":"2019","unstructured":"Ludwig N, Whiteside TL, Reichert TE (2019) Challenges in exosome isolation and analysis in health and disease. Int J Mol Sci 20(19):4684","journal-title":"Int J Mol Sci"},{"issue":"23","key":"5026_CR232","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1158\/0008-5472.CAN-17-0994","volume":"77","author":"CF Ruivo","year":"2017","unstructured":"Ruivo CF, Adem B, Silva M, Melo SA (2017) The biology of cancer exosomes: insights and new perspectives. Cancer Res 77(23):6480\u20136488","journal-title":"Cancer Res"},{"key":"5026_CR233","doi-asserted-by":"publisher","first-page":"100278","DOI":"10.1016\/j.jlb.2024.100278","volume":"6","author":"A Thakur","year":"2024","unstructured":"Thakur A, Rai D (2024) Global requirements for manufacturing and validation of clinical grade extracellular vesicles. J Liquid Biopsy 6:100278. https:\/\/doi.org\/10.1016\/j.jlb.2024.100278","journal-title":"J Liquid Biopsy"},{"issue":"8","key":"5026_CR234","doi-asserted-by":"publisher","first-page":"e13904","DOI":"10.1111\/cts.13904","volume":"17","author":"CK Wang","year":"2024","unstructured":"Wang CK, Tsai TH, Lee CH (2024) Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci 17(8):e13904","journal-title":"Clin Transl Sci"},{"issue":"12","key":"5026_CR235","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/14737159.2023.2277373","volume":"23","author":"Y Couch","year":"2023","unstructured":"Couch Y (2023) Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease. Expert Rev Mol Diagn 23(12):1091\u20131105","journal-title":"Expert Rev Mol Diagn"},{"issue":"3","key":"5026_CR236","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s40520-023-02349-3","volume":"35","author":"X Xiao","year":"2023","unstructured":"Xiao X, Xiang S, Xu Q, Li J, Xiao J, Si Y (2023) Comorbidity among inpatients with dementia: a preliminary cross-sectional study in West China. Aging Clin Exp Res 35(3):659\u2013667","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"5026_CR237","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/02537176221130252","volume":"45","author":"BP Varkey","year":"2023","unstructured":"Varkey BP, Joseph J, Haokip HR, Sharma SK, Mathews E, Ameen S et al (2023) The prevalence of comorbidities and associated factors among patients with dementia in the Indian setting: Meta-analysis of observational studies. Indian J Psychol Med 45(4):338\u2013344","journal-title":"Indian J Psychol Med"},{"issue":"2","key":"5026_CR238","doi-asserted-by":"publisher","first-page":"e019325","DOI":"10.1136\/bmjopen-2017-019325","volume":"8","author":"TM Kringelbach","year":"2018","unstructured":"Kringelbach TM, Glintborg B, Hogdall EV, Johansen JS, Hetland ML (2018) Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study. BMJ Open 8(2):e019325","journal-title":"BMJ Open"},{"issue":"1","key":"5026_CR239","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/s41467-022-30227-5","volume":"13","author":"I Thomas","year":"2022","unstructured":"Thomas I, Dickens AM, Posti JP, Czeiter E, Duberg D, Sinioja T et al (2022) Serum metabolome associated with severity of acute traumatic brain injury. Nat Commun 13(1):2545","journal-title":"Nat Commun"},{"key":"5026_CR240","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fnins.2017.00026","volume":"11","author":"FN Soria","year":"2017","unstructured":"Soria FN, Pampliega O, Bourdenx M, Meissner WG, Bezard E, Dehay B (2017) Exosomes, an Unmasked Culprit in Neurodegenerative Diseases. Front Neurosci 11:26","journal-title":"Front Neurosci"},{"issue":"8","key":"5026_CR241","doi-asserted-by":"publisher","first-page":"e99263","DOI":"10.1172\/jci.insight.99263","volume":"3","author":"M Mendt","year":"2018","unstructured":"Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu C-C, Gagea M et al (2018) Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI insight 3(8):e99263","journal-title":"JCI insight"},{"issue":"3","key":"5026_CR242","doi-asserted-by":"publisher","first-page":"e14435","DOI":"10.1111\/cns.14435","volume":"30","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wang H, Zhao X, Han C, Liu C, Li Z et al (2024) Transcriptome sequencing of circular RNA reveals the involvement of hsa-SCMH1_0001 in the pathogenesis of Parkinson\u2019s disease. CNS Neurosci Ther 30(3):e14435","journal-title":"CNS Neurosci Ther"},{"key":"5026_CR243","doi-asserted-by":"publisher","first-page":"116863","DOI":"10.1016\/j.bios.2024.116863","volume":"267","author":"M Park","year":"2025","unstructured":"Park M, Lee C-H, Noh H, Kang G, Lee J, Bae J-H et al (2025) High-precision extracellular-vesicle isolation-analysis integrated platform for rapid cancer diagnosis directly from blood plasma. Biosens Bioelectron 267:116863","journal-title":"Biosens Bioelectron"},{"issue":"18","key":"5026_CR244","doi-asserted-by":"publisher","first-page":"8926","DOI":"10.7150\/thno.62330","volume":"11","author":"M Xu","year":"2021","unstructured":"Xu M, Feng T, Liu B, Qiu F, Xu Y, Zhao Y et al (2021) Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics 11(18):8926\u20138944","journal-title":"Theranostics"},{"key":"5026_CR245","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.procbio.2019.06.025","volume":"85","author":"N Seyfizadeh","year":"2019","unstructured":"Seyfizadeh N, Seyfizadeh N, Borzouisileh S, Elahimanesh F, Hosseini V, Nouri M (2019) Exosome-mediated therapeutic delivery: a new horizon for human neurodegenerative disorders\u2019 treatment (with a focus on siRNA delivery improvement). Process Biochem 85:164\u2013174","journal-title":"Process Biochem"},{"issue":"10","key":"5026_CR246","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X (2023) Current strategies for exosome cargo loading and targeting delivery. Cells 12(10):1416","journal-title":"Cells"},{"issue":"2","key":"5026_CR247","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/pr9020356","volume":"9","author":"Y Han","year":"2021","unstructured":"Han Y, Jones TW, Dutta S, Zhu Y, Wang X, Narayanan SP et al (2021) Overview and update on methods for cargo loading into extracellular vesicles. Processes 9(2):356","journal-title":"Processes"},{"issue":"11","key":"5026_CR248","doi-asserted-by":"publisher","first-page":"7907","DOI":"10.1021\/acsnano.3c09378","volume":"18","author":"D Wu","year":"2024","unstructured":"Wu D, Sun H, Yang B, Song E, Song Y, Tan W (2024) Exosome heterogeneity affects the distal \u201cBarrier-Crossing\u201d trafficking of exosome encapsulated quantum dots. ACS Nano 18(11):7907\u20137922","journal-title":"ACS Nano"},{"issue":"1","key":"5026_CR249","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-024-03868-0","volume":"15","author":"M Akhlaghpasand","year":"2024","unstructured":"Akhlaghpasand M, Tavanaei R, Hosseinpoor M, Yazdani KO, Soleimani A, Zoshk MY et al (2024) Safety and potential effects of intrathecal injection of allogeneic human umbilical cord mesenchymal stem cell-derived exosomes in complete subacute spinal cord injury: a first-in-human, single-arm, open-label, phase I clinical trial. Stem Cell Res Ther 15(1):264","journal-title":"Stem Cell Res Ther"},{"issue":"Suppl 2","key":"5026_CR250","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41409-019-0616-z","volume":"54","author":"M Mendt","year":"2019","unstructured":"Mendt M, Rezvani K, Shpall E (2019) Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant 54(Suppl 2):789\u2013792","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"5026_CR251","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/med.22002","volume":"44","author":"CY Ma","year":"2024","unstructured":"Ma CY, Zhai Y, Li CT, Liu J, Xu X, Chen H et al (2024) Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: promises, problems and prospects. Med Res Rev 44(3):919\u2013938","journal-title":"Med Res Rev"},{"issue":"759","key":"5026_CR252","doi-asserted-by":"publisher","first-page":"eadi4830","DOI":"10.1126\/scitranslmed.adi4830","volume":"16","author":"J Han","year":"2024","unstructured":"Han J, Sul JH, Lee J, Kim E, Kim HK, Chae M et al (2024) Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas\u2013based epigenome editing in Alzheimer\u2019s disease. Sci Trans Med 16(759):eadi4830","journal-title":"Sci Trans Med"},{"key":"5026_CR253","doi-asserted-by":"publisher","first-page":"RP90390","DOI":"10.7554\/eLife.90390","volume":"12","author":"B Li","year":"2024","unstructured":"Li B, Kugeratski FG, Kalluri R (2024) A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes. Elife 12:RP90390","journal-title":"Elife"},{"key":"5026_CR254","doi-asserted-by":"publisher","first-page":"114974","DOI":"10.1016\/j.addr.2023.114974","volume":"199","author":"ZF Greenberg","year":"2023","unstructured":"Greenberg ZF, Graim KS, He M (2023) Towards artificial intelligence-enabled extracellular vesicle precision drug delivery. Adv Drug Deliv Rev 199:114974","journal-title":"Adv Drug Deliv Rev"},{"key":"5026_CR255","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH (2018) Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther 9:1\u20139","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5026_CR256","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-021-02138-7","volume":"12","author":"Y Tang","year":"2021","unstructured":"Tang Y, Zhou Y, Li H-J (2021) Advances in mesenchymal stem cell exosomes: a review. Stem Cell Res Ther 12(1):71","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5026_CR257","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00604-024-06862-8","volume":"192","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhao Y, Hu H, Lv M, Zhang H (2025) A colorimetric nano-enzyme assay with Ni@ Pt nanoparticles as signal labels for rapid and sensitive detection of exosomal A\u03b242 in plasma. Microchim Acta 192(1):53","journal-title":"Microchim Acta"},{"key":"5026_CR258","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.omtm.2019.06.005","volume":"14","author":"NS Orefice","year":"2019","unstructured":"Orefice NS, Souchet B, Braudeau J, Alves S, Piguet F, Collaud F et al (2019) Real-time monitoring of exosome enveloped-AAV spreading by endomicroscopy approach: a new tool for gene delivery in the brain. Mole Ther Meth Clin Develop 14:237\u2013251","journal-title":"Mole Ther Meth Clin Develop"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05026-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05026-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05026-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:03:21Z","timestamp":1760036601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05026-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":258,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5026"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05026-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}